Manuel, M., Tredan, O., Bachelot, T., Clapisson, G., Courtier, A., Parmentier, G., . . . Ménétrier-Caux, C. (2012). Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. Landes Bioscience.
استشهاد بنمط شيكاغوManuel, Manuarii, et al. Lymphopenia Combined With Low TCR Diversity (divpenia) Predicts Poor Overall Survival in Metastatic Breast Cancer Patients. Landes Bioscience, 2012.
MLA استشهادManuel, Manuarii, et al. Lymphopenia Combined With Low TCR Diversity (divpenia) Predicts Poor Overall Survival in Metastatic Breast Cancer Patients. Landes Bioscience, 2012.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.